TODDLASCOTODD LASCO13953LASCO, TODDAssistant Professorprns:coAuthorOfcoauthor ofFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:address1address line 1vivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provincevivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentDivisionvivo:hasResearchArearesearch areasvivo:hrJobTitleHR job titleInformation Resourcevivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson25445120Aitken SL, Hemmige VS, Koo HL, Vuong NN, Lasco TM, Garey KWDiagnostic microbiology and infectious diseaseReal-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship. Diagn Microbiol Infect Dis. 2015 Jan; 81(1):4-8.Diagn Microbiol Infect Dis2014-10-02T00:00:002014Real-world performance of a microarray-based rapid diagnostic for Gram-positive bloodstream infections and potential utility for antimicrobial stewardship.AMELIASOFJANAMELIA K. SOFJAN8284SOFJAN, AMELIAClinical Assistant ProfessorNICHOLASBEYDANICHOLAS D. BEYDA8286BEYDA, NICHOLASAssistant Professor25932438Kilic A, Alam MJ, Tisdel NL, Shah DN, Yapar M, Lasco TM, Garey KWAnnals of laboratory medicineMultiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples. Ann Lab Med. 2015 May; 35(3):306-13.Ann Lab Med2015-04-01T00:00:002015Multiplex Real-Time PCR Method for Simultaneous Identification and Toxigenic Type Characterization of Clostridium difficile From Stool Samples.Infectious Diseases, Infection Control, and Employee HealthMD AndersonISSAM IRAADISSAM I RAAD8617RAAD, ISSAM IProfessorDIMITRIOS PKONTOYIANNISDIMITRIOS P KONTOYIANNIS8761KONTOYIANNIS, DIMITRIOS PProfessor25989841Nesher L, Hadi CM, Salazar L, Wootton SH, Garey KW, Lasco T, Luce AM, Hasbun REpidemiology and infectionEpidemiology of meningitis with a negative CSF Gram stain: under-utilization of available diagnostic tests. Epidemiol Infect. 2016 Jan; 144(1):189-97.Epidemiol Infect2015-05-20T00:00:002015Epidemiology of meningitis with a negative CSF Gram stain: under-utilization of available diagnostic tests.74Professor10Assistant Professor27Clinical Assistant Professor21Chair21700622Shah DN, Yau R, Weston J, Lasco TM, Salazar M, Palmer HR, Garey KWThe Journal of antimicrobial chemotherapyEvaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. J Antimicrob Chemother. 2011 Sep; 66(9):2146-51.J Antimicrob Chemother2011-06-23T00:00:002011Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes.MAYARAL MOHAJERMAYAR AL MOHAJER12762AL MOHAJER, MAYARProfessor28228898McConnell MF, Shi A, Lasco TM, Yoon LRadiology case reportsDisseminated coccidioidomycosis with multifocal musculoskeletal disease involvement. Radiol Case Rep. 2017 Mar; 12(1):141-145.Radiol Case Rep2016-12-23T00:00:002016Disseminated coccidioidomycosis with multifocal musculoskeletal disease involvement.22411611Shah DN, Yau R, Lasco TM, Weston J, Salazar M, Palmer HR, Garey KWAntimicrobial agents and chemotherapyImpact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia. Antimicrob Agents Chemother. 2012 Jun; 56(6):3239-43.Antimicrob Agents Chemother2012-03-12T00:00:002012Impact of prior inappropriate fluconazole dosing on isolation of fluconazole-nonsusceptible Candida species in hospitalized patients with candidemia.22764323Tam VH, Hirsch EB, Lasco TM, Gentry LO, Palmer HRThe Annals of pharmacotherapyCorrelation of hospital carbapenem consumption and resistance trends in selected gram-negative bacteria. Ann Pharmacother. 2012 Jul-Aug; 46(7-8):1120-2.Ann Pharmacother2012-07-03T00:00:002012Correlation of hospital carbapenem consumption and resistance trends in selected gram-negative bacteria.23345420McGrath DM, Barbu EM, Driessen WH, Lasco TM, Tarrand JJ, Okhuysen PC, Kontoyiannis DP, Sidman RL, Pasqualini R, Arap WProceedings of the National Academy of Sciences of the United States of AmericaMechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic. Proc Natl Acad Sci U S A. 2013 Feb 26; 110(9):3477-82.Proc Natl Acad Sci U S A2013-01-23T00:00:002013Mechanism of action and initial evaluation of a membrane active all-D-enantiomer antimicrobial peptidomimetic.23545528Huang JS, Jiang ZD, Garey KW, Lasco T, Dupont HLAntimicrobial agents and chemotherapyUse of rifamycin drugs and development of infection by rifamycin-resistant strains of Clostridium difficile. Antimicrob Agents Chemother. 2013 Jun; 57(6):2690-3.Antimicrob Agents Chemother2013-04-01T00:00:002013Use of rifamycin drugs and development of infection by rifamycin-resistant strains of Clostridium difficile.21251574Hirsch EB, Chang KT, Lasco TM, Caeiro JP, Tam VHDiagnostic microbiology and infectious diseaseEmergence of KPC-producing Klebsiella pneumoniae in Texas. Diagn Microbiol Infect Dis. 2011 Feb; 69(2):234-5.Diagn Microbiol Infect Dis2011-02-01T00:00:002011Emergence of KPC-producing Klebsiella pneumoniae in Texas.23223589Jiang ZD, Hoang LN, Lasco TM, Garey KW, Dupont HLClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaPhysician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area. Clin Infect Dis. 2013 Apr; 56(7):1059-60.Clin Infect Dis2012-12-07T00:00:002012Physician attitudes toward the use of fecal transplantation for recurrent Clostridium difficile infection in a metropolitan area.29125052Abodakpi H, Chang KT, S?nchez D?az AM, Cant?n R, Lasco TM, Chan K, Sofjan AK, Tam VHJournal of chemotherapy (Florence, Italy)Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital. J Chemother. 2018 Apr; 30(2):115-119.J Chemother2017-11-10T00:00:002017Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital.6720 BERTNERHouston, 77030TX1.013960.0051373241research areas2.734220.028814917coauthor of38.0492.70360similar to1147selected publicationsAuthorship 8864243Authorship 8864874Authorship 8865414Authorship 8866493Authorship 8866853Authorship 8867815Authorship 8868483Authorship 8868755Authorship 8869029Authorship 8869037Authorship 8869394Authorship 8869854Authorship 8870136Authorship 8871255Authorship 8885123Authorship 8886246Authorship 8899433D014397Disorders722460.793903Tuberculosis, PulmonaryD001426Chemicals & Drugs29510270.63131Bacterial ProteinsD006168Living Beings922410.963577Guinea PigsAuthorship 8955633Authorship 8963781Authorship 8968311Authorship 8968663Authorship 8972547Authorship 8975349Authorship 8975934Authorship 8975992Authorship 8976136Authorship 8980351Authorship 8983683Authorship 8987791Authorship 8996152Authorship 8998293Authorship 9086746Authorship 9132565Authorship 9192533Authorship 92493559515912B?umler AJ, Norris TL, Lasco T, Voight W, Reissbrodt R, Rabsch W, Heffron FJournal of bacteriologyIroN, a novel outer membrane siderophore receptor characteristic of Salmonella enterica. J Bacteriol. 1998 Mar; 180(6):1446-53.J Bacteriol1998-03-01T00:00:001998IroN, a novel outer membrane siderophore receptor characteristic of Salmonella enterica.14742563Lasco TM, Turner OC, Cassone L, Sugawara I, Yamada H, McMurray DN, Orme IMInfection and immunityRapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis. Infect Immun. 2004 Feb; 72(2):1147-9.Infect Immun2004-02-01T00:00:002004Rapid accumulation of eosinophils in lung lesions in guinea pigs infected with Mycobacterium tuberculosis.14638793Lasco TM, Yamamoto T, Yoshimura T, Allen SS, Cassone L, McMurray DNInfection and immunityEffect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations. Infect Immun. 2003 Dec; 71(12):7035-42.Infect Immun2003-12-01T00:00:002003Effect of Mycobacterium bovis BCG vaccination on Mycobacterium-specific cellular proliferation and tumor necrosis factor alpha production from distinct guinea pig leukocyte populations.14977939Allen SS, Cassone L, Lasco TM, McMurray DNInfection and immunityEffect of neutralizing transforming growth factor beta1 on the immune response against Mycobacterium tuberculosis in guinea pigs. Infect Immun. 2004 Mar; 72(3):1358-63.Infect Immun2004-03-01T00:00:002004Effect of neutralizing transforming growth factor beta1 on the immune response against Mycobacterium tuberculosis in guinea pigs.15687024Izzo A, Brandt L, Lasco T, Kipnis AP, Orme ITuberculosis (Edinburgh, Scotland)NIH pre-clinical screening program: overview and current status. Tuberculosis (Edinb). 2005 Jan-Mar; 85(1-2):25-8.Tuberculosis (Edinb)2005-01-17T00:00:002005NIH pre-clinical screening program: overview and current status.15731034Cho H, Lasco TM, Allen SS, Yoshimura T, McMurray DNInfection and immunityRecombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages. Infect Immun. 2005 Mar; 73(3):1367-76.Infect Immun2005-03-01T00:00:002005Recombinant guinea pig tumor necrosis factor alpha stimulates the expression of interleukin-12 and the inhibition of Mycobacterium tuberculosis growth in macrophages.15501795Brandt L, Skeiky YA, Alderson MR, Lobet Y, Dalemans W, Turner OC, Basaraba RJ, Izzo AA, Lasco TM, Chapman PL, Reed SG, Orme IMInfection and immunityThe protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs. Infect Immun. 2004 Nov; 72(11):6622-32.Infect Immun2004-11-01T00:00:002004The protective effect of the Mycobacterium bovis BCG vaccine is increased by coadministration with the Mycobacterium tuberculosis 72-kilodalton fusion polyprotein Mtb72F in M. tuberculosis-infected guinea pigs.15958260Lasco TM, Cassone L, Kamohara H, Yoshimura T, McMurray DNTuberculosis (Edinburgh, Scotland)Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig. Tuberculosis (Edinb). 2005 Jul; 85(4):245-58.Tuberculosis (Edinb)2005-03-03T00:00:002005Evaluating the role of tumor necrosis factor-alpha in experimental pulmonary tuberculosis in the guinea pig.16368975Jeevan A, McFarland CT, Yoshimura T, Skwor T, Cho H, Lasco T, McMurray DNInfection and immunityProduction and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation. Infect Immun. 2006 Jan; 74(1):213-24.Infect Immun2006-01-01T00:00:002006Production and characterization of guinea pig recombinant gamma interferon and its effect on macrophage activation.16198325Saalm?ller A, Lunney JK, Daubenberger C, Davis W, Fischer U, G?bel TW, Griebel P, Hollemweguer E, Lasco T, Meister R, Schuberth HJ, Sestak K, Sopp P, Steinbach F, Xiao-Wei W, Aasted BCellular immunologySummary of the animal homologue section of HLDA8. Cell Immunol. 2005 Jul-Aug; 236(1-2):51-8.Cell Immunol2005-09-29T00:00:002005Summary of the animal homologue section of HLDA8.16253558McMurray DN, Allen SS, Jeevan A, Lasco T, Cho H, Skwor T, Yamamoto T, McFarland C, Yoshimura TTuberculosis (Edinburgh, Scotland)Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis. Tuberculosis (Edinb). 2005 Sep-Nov; 85(5-6):295-301.Tuberculosis (Edinb)2005-10-25T00:00:002005Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.17289434Yamamoto T, Lasco TM, Uchida K, Goto Y, Jeevan A, McFarland C, Ly L, Yamamoto S, McMurray DNTuberculosis (Edinburgh, Scotland)Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs. Tuberculosis (Edinb). 2007 Mar; 87(2):155-65.Tuberculosis (Edinb)2007-02-07T00:00:002007Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.17658620Lasco TM, Gonzalez-Juarrero M, Saalm?ller A, Lunney JKVeterinary immunology and immunopathologyCross-reaction of anti-human CD monoclonal antibodies on guinea pig cells: a summary of the guinea pig section of the HLDA8 animal homologues data. Vet Immunol Immunopathol. 2007 Sep 15; 119(1-2):131-6.Vet Immunol Immunopathol2007-06-20T00:00:002007Cross-reaction of anti-human CD monoclonal antibodies on guinea pig cells: a summary of the guinea pig section of the HLDA8 animal homologues data.19896449Skeiky YA, Dietrich J, Lasco TM, Stagliano K, Dheenadhayalan V, Goetz MA, Cantarero L, Basaraba RJ, Bang P, Kromann I, McMclain JB, Sadoff JC, Andersen PVaccineNon-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen. Vaccine. 2010 Jan 22; 28(4):1084-93.Vaccine2009-11-05T00:00:002009Non-clinical efficacy and safety of HyVac4:IC31 vaccine administered in a BCG prime-boost regimen.26618357Biehle LR, Cottreau JM, Thompson DJ, Filipek RL, O'Donnell JN, Lasco TM, Mahoney MV, Hirsch EBPloS oneOutcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia. PLoS One. 2015; 10(11):e0143845.PLoS One2015-11-30T00:00:002015Outcomes and Risk Factors for Mortality among Patients Treated with Carbapenems for Klebsiella spp. Bacteremia.28535946Chen A, Smith KP, Whitfield BA, Zucchi PC, Lasco TM, Bias TE, Kirby JE, Hirsch EBDiagnostic microbiology and infectious diseaseActivity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline. Diagn Microbiol Infect Dis. 2017 Aug; 88(4):365-367.Diagn Microbiol Infect Dis2017-05-11T00:00:002017Activity of minocycline against Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae clinical isolates, with comparison to doxycycline and tigecycline.29101084Skoglund E, Ledesma KR, Lasco TM, Tam VHJournal of global antimicrobial resistanceCeftolozane/tazobactam activity against meropenem-non-susceptible Pseudomonas aeruginosa bloodstream infection isolates. J Glob Antimicrob Resist. 2017 12; 11:154-155.J Glob Antimicrob Resist2017-10-31T00:00:002017Ceftolozane/tazobactam activity against meropenem-non-susceptible Pseudomonas aeruginosa bloodstream infection isolates.29842975Sofjan AK, Musgrove RJ, Beyda ND, Russo HP, Lasco TM, Yau R, Restrepo A, Garey KWJournal of global antimicrobial resistancePrevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA. J Glob Antimicrob Resist. 2018 12; 15:41-47.J Glob Antimicrob Resist2018-05-26T00:00:002018Prevalence and predictors of spontaneous bacterial peritonitis due to ceftriaxone-resistant organisms at a large tertiary centre in the USA.D001618Chemicals & Drugs501780.828365beta-LactamasesD007711Living Beings55980.918208Klebsiella pneumoniaeDepartment of MedicineDepartment of Pathology & ImmunologyMedicine-Infectious DiseasePathologyBaylor College of MedicineUniversity of Houston College of PharmacyVINCENTTAMVINCENT H. TAM29.70508570000000-95.401808700000004595TAM, VINCENTProfessorKEVINGAREYKEVIN W. GAREY29.70508570000000-95.401808700000004636GAREY, KEVINProfessor. Chair, Department of Pharmacy Practice and Translational Research.TIMOTHYPALZKILLTIMOTHY PALZKILL0.000000000000000.000000000000003364PALZKILL, TIMOTHYChair80Professor. Chair, Department of Pharmacy Practice and Translational Research.true1Professor. Chair, Department of Pharmacy Practice and Translational Research.Professor. Chair, Department of Pharmacy Practice and Translational Research.true1ProfessorProfessortrue1Clinical Assistant ProfessorClinical Assistant Professortrue1Assistant ProfessorAssistant ProfessorPharmacy Practice and Translational Researchtrue1Assistant ProfessorAssistant ProfessorAuthorship 979771532131910Watson KJ, Trautner B, Russo H, Phe K, Lasco T, Pipkins T, Lembcke B, Al Mohajer MInfection control and hospital epidemiologyUsing clinical decision support to improve urine culture diagnostic stewardship, antimicrobial stewardship, and financial cost: A multicenter experience. Infect Control Hosp Epidemiol. 2020 05; 41(5):564-570.Infect Control Hosp Epidemiol2020-03-05T00:00:002020Using clinical decision support to improve urine culture diagnostic stewardship, antimicrobial stewardship, and financial cost: A multicenter experience.Authorship 1004730533166758Zidaru A, Eales BM, Wang W, Merlau PR, Lasco TM, Sofjan AK, Tam VHJournal of global antimicrobial resistanceMIC profiling of ceftazidime/avibactam against two carbapenemase-producing Klebsiella pneumoniae isolates. J Glob Antimicrob Resist. 2020 12; 23:385-387.J Glob Antimicrob Resist2020-11-06T00:00:002020MIC profiling of ceftazidime/avibactam against two carbapenemase-producing Klebsiella pneumoniae isolates.Authorship 1012064333610788Al Mohajer M, Panthagani KM, Lasco T, Lembcke B, Hemmige VInternational journal of infectious diseases : IJID : official publication of the International Society for Infectious DiseasesAssociation between universal face shield in a quaternary care center and reduction of SARS-COV2 infections among healthcare personnel and hospitalized patients. Int J Infect Dis. 2021 Apr; 105:252-255.Int J Infect Dis2021-02-18T00:00:002021Association between universal face shield in a quaternary care center and reduction of SARS-COV2 infections among healthcare personnel and hospitalized patients.Authorship 1024871234250186Centeno FH, Lasco T, Ahmed AA, Al Mohajer MOpen forum infectious diseasesCharacteristics of Rickettsia typhi Infections Detected with Next-Generation Sequencing of Microbial Cell-Free Deoxyribonucleic Acid in a Tertiary Care Hospital. Open Forum Infect Dis. 2021 Jul; 8(7):ofab147.Open Forum Infect Dis2021-03-26T00:00:002021Characteristics of Rickettsia typhi Infections Detected with Next-Generation Sequencing of Microbial Cell-Free Deoxyribonucleic Acid in a Tertiary Care Hospital.Authorship 1034649334849535Zidaru A, Phe K, Lasco TM, Tam VHAmerican journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System PharmacistsAn integrated approach to evaluate different tetracycline derivatives for formulary decisions. Am J Health Syst Pharm. 2022 03 07; 79(6):467-471.Am J Health Syst Pharm2022-03-07T00:00:002022An integrated approach to evaluate different tetracycline derivatives for formulary decisions.true1ProfessorProfessorAuthorship 1064991436865703Francisco DMA, Woc-Colburn L, Carlson TJ, Lasco T, Barrett M, Al Mohajer MAntimicrobial stewardship & healthcare epidemiology : ASHEThe effect of a plasma next-generation sequencing test on antimicrobial management in immunocompetent and immunocompromised patients-A single-center retrospective study. Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e31.Antimicrob Steward Healthc Epidemiol2023-02-17T00:00:002023The effect of a plasma next-generation sequencing test on antimicrobial management in immunocompetent and immunocompromised patients-A single-center retrospective study.Authorship 1068234437067155Zaki A, Gonzales-Luna AJ, Beyda ND, Lasco T, Garey KWPharmacotherapyMicafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species. Pharmacotherapy. 2023 06; 43(6):466-472.Pharmacotherapy2023-04-30T00:00:002023Micafungin pharmacodynamics predict clinical outcomes in hospitalized patients with candidemia caused by certain Candida species.Authorship 1070203237152189Al Mohajer M, Lasco TOpen forum infectious diseasesThe Impact of Initial Specimen Diversion Systems on Blood Culture Contamination. Open Forum Infect Dis. 2023 May; 10(5):ofad182.Open Forum Infect Dis2023-04-05T00:00:002023The Impact of Initial Specimen Diversion Systems on Blood Culture Contamination.true1ChairChairDepartment of Biochemistry and Molecular PharmacologyBiochemistry & Mol PharmacologyAuthorship 1077642737592964Kelly GA, Iordanov R, Franklin A, Ahmed A, Srinivasan K, Hayon J, Lasco T, Amini R, Shay S, Kulkarni PA, Al Mohajer MAntimicrobial stewardship & healthcare epidemiology : ASHEImpact of gastrointestinal polymerase chain reaction panels on antibiotic utilization in hospitalized adult patients. Antimicrob Steward Healthc Epidemiol. 2023; 3(1):e135.Antimicrob Steward Healthc Epidemiol2023-08-02T00:00:002023Impact of gastrointestinal polymerase chain reaction panels on antibiotic utilization in hospitalized adult patients.Authorship 1085710738088164Wang MC, Zhou KJ, Shay SL, Herlihy JP, Siddique MA, Trevino Castillo S, Lasco TM, Barrett M, Al Mohajer MInfection control and hospital epidemiologyThe impact of a blood-culture diagnostic stewardship intervention on utilization rates and antimicrobial stewardship. Infect Control Hosp Epidemiol. 2023 Dec 13; 1-4.Infect Control Hosp Epidemiol2023-12-13T00:00:002023The impact of a blood-culture diagnostic stewardship intervention on utilization rates and antimicrobial stewardship.Authorship 1088771638362111Kelly G, Hudson M, Apple B, Bundage D, Lembcke B, Lasco T, Al Mohajer MJournal of infection preventionDiscontinuation of contact precautions in patients with hospital-acquired MRSA and VRE infections during the COVID-19 pandemic: A multi-center experience. J Infect Prev. 2024 Mar; 25(1-2):33-37.J Infect Prev2023-10-16T00:00:002023Discontinuation of contact precautions in patients with hospital-acquired MRSA and VRE infections during the COVID-19 pandemic: A multi-center experience.Authorship 1089779338415091Centeno FH, Hamdi AM, Lasco TM, Al Mohajer MAntimicrobial stewardship & healthcare epidemiology : ASHEDetection of invasive Bartonella infections with next-generation sequencing of microbial cell-free DNA. Antimicrob Steward Healthc Epidemiol. 2024; 4(1):e20.Antimicrob Steward Healthc Epidemiol2024-02-12T00:00:002024Detection of invasive Bartonella infections with next-generation sequencing of microbial cell-free DNA.true1ProfessorProfessortrue1ProfessorProfessor24674388Hirsch EB, Chang KT, Zucchi PC, Francoeur DN, Ledesma KR, Tam VH, Lasco TMJournal of infection and chemotherapy : official journal of the Japan Society of ChemotherapyAn evaluation of multiple phenotypic screening methods for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae. J Infect Chemother. 2014 Mar; 20(3):224-7.J Infect Chemother2013-12-11T00:00:002013An evaluation of multiple phenotypic screening methods for Klebsiella pneumoniae carbapenemase (KPC)-producing Enterobacteriaceae.24687545Aitken SL, Beyda ND, Shah DN, Palmer HR, Lasco TM, Koo H, Garey KWThe Annals of pharmacotherapyClinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics. Ann Pharmacother. 2014 Jun; 48(6):683-90.Ann Pharmacother2014-03-31T00:00:002014Clinical practice patterns in hospitalized patients at risk for invasive candidiasis: role of antifungal stewardship programs in an era of rapid diagnostics.24799643Koo HL, Van JN, Zhao M, Ye X, Revell PA, Jiang ZD, Grimes CZ, Koo DC, Lasco T, Kozinetz CA, Garey KW, DuPont HLInfection control and hospital epidemiologyReal-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates. Infect Control Hosp Epidemiol. 2014 Jun; 35(6):667-73.Infect Control Hosp Epidemiol2014-04-22T00:00:002014Real-time polymerase chain reaction detection of asymptomatic Clostridium difficile colonization and rising C. difficile-associated disease rates.25057871Aitken SL, Joseph TB, Shah DN, Lasco TM, Palmer HR, DuPont HL, Xie Y, Garey KWPloS oneHealthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas. PLoS One. 2014; 9(7):e102848.PLoS One2014-07-24T00:00:002014Healthcare resource utilization for recurrent Clostridium difficile infection in a large university hospital in Houston, Texas.24879785Beyda ND, John J, Kilic A, Alam MJ, Lasco TM, Garey KWClinical infectious diseases : an official publication of the Infectious Diseases Society of AmericaFKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia. Clin Infect Dis. 2014 Sep 15; 59(6):819-25.Clin Infect Dis2014-05-30T00:00:002014FKS mutant Candida glabrata: risk factors and outcomes in patients with candidemia.